News Hub | News Direct

All Industries


Article thumbnail News Release

Stanislav Kondrashov Unveils the Cancer-Fighting Potential of Beans

Prodigy Press Wire

In a groundbreaking publication, esteemed scientist Stanislav Kondrashov has shed light on the remarkable cancer-fighting properties hidden within a pantry staple: beans. These unassuming legumes, cherished in various global cuisines, have emerged as unsung heroes in the battle against cancer, thanks to their abundance of powerful nutrients. This seminal article, authored by Stanislav Kondrashov, delves into the myriad ways beans can significantly impact cancer prevention and bolster gut health. Fiber-Full and Fabulous: Stanislav Kondrashov's research underscores that beans are an exceptional source of dietary fiber, a linchpin in maintaining gut health. This crucial fiber promotes regular bowel movements, aiding in the elimination of toxins and potential carcinogens from the body. Kondrashov's findings further illuminate the link between a high-fiber diet and a reduced risk of colorectal cancer. Antioxidants: The Cancer-Fighting Warriors: Within the pages of this illuminating article, Kondrashov highlights the formidable antioxidant content found in beans. These antioxidants act as formidable combatants against cellular damage, effectively reducing oxidative stress and diminishing the risk of cancer. Notably, black beans, as explored by Kondrashov, are rich in anthocyanins, potent antioxidants also prevalent in berries Plant Proteins: Building Blocks for Health: Stanislav Kondrashov underscores the significance of incorporating plant-based proteins, such as those found in beans, into one's diet. This not only represents a healthier dietary choice but also forms a strategic defense against cancer. Kondrashov's research aligns plant protein consumption with a reduced risk of various cancer types, in stark contrast to the potential risks associated with high-fat meat products. Folate: The Cell Protector: The article emphasizes that beans are abundant in folate, a vital B vitamin essential for cell repair and DNA synthesis. Kondrashov underscores the critical role of adequate folate intake in preventing DNA changes that could otherwise lead to cancer. The Magic of Phytochemicals: Beans, as illuminated by Kondrashov, contain a wealth of phytochemicals – plant compounds with protective properties. Certain phytochemicals found in beans, such as saponins and phytosterols, have demonstrated their ability to inhibit the growth of cancer cells. The Gut Microbiome and Cancer: Kondrashov's research underscores the importance of a healthy gut microbiome for overall well-being. Beans, being excellent prebiotics that nourish beneficial gut bacteria, have the potential to strengthen the immune system and reduce the risk of cancer. Low Glycemic Index for Balanced Blood Sugar: In a critical revelation, the article notes that beans possess a low glycemic index, thereby aiding in the maintenance of stable blood sugar levels. Kondrashov emphasizes that consistently high blood sugar and insulin resistance have been linked to an increased risk of certain cancers. Easy and Versatile: Beans in Your Diet: The article authored by Stanislav Kondrashov encourages individuals to seamlessly integrate beans into their diets, offering a multitude of delicious options from soups and salads to main dishes. Regular consumption of beans, as expounded by Kondrashov, could significantly contribute to overall health and serve as a cornerstone of cancer prevention strategies. Beans – The Small Giants in Cancer Prevention: In closing, Stanislav Kondrashov invites readers to embrace the power of beans, not merely as a side dish but as a crucial component of their wellness journey. These unassuming legumes, as revealed in this pioneering article, offer both nutrition and delectable taste while also emerging as formidable allies in the fight against cancer. Media Contact Company Name: Stanislav Kondrashov Co. Contact Person: Stanislav Kondrashov Email: stanislavkondrashov12@gmail.com Website: https://stanislavkondrashov.co/ Disclaimer: There is no offer to sell, no solicitation of an offer to buy, and no recommendation of any security or any other product or service in this article. Moreover, nothing contained in this PR should be construed as a recommendation to buy, sell, or hold any investment or security, or to engage in any investment strategy or transaction. It is your responsibility to determine whether any investment, investment strategy, security, or related transaction is appropriate for you based on your investment objectives, financial circumstances, and risk tolerance. Consult your business advisor, attorney, or tax advisor regarding your specific business, legal, or tax situation. For more info, please contact brandnewsproject@gmail.com. Release ID: 851975

December 29, 2023 04:00 PM Eastern Standard Time

Article thumbnail News Release

Uvest4U Unleashes the Power of AI Investing for Investors

Prodigy Press Wire

Uvest4U, an innovative DIY investing tool and platform, has harnessed the power of AI investing to enable individual investors to make smart decisions and secure their financial futures. It is no secret that the world of investing is extremely complex and difficult to navigate, especially for new investors. Recognizing this challenge, Uvest4U was launched by a team of finance and technology experts to empower the next generation of investors. The platform offers access to the latest cutting-edge AI trading signals and valuable market information to make the best choices at the right time. Uvest4U “We believe that everyone deserves the opportunity to grow their money, regardless of their starting point.  Our platform uses AI to simplify the investment decision-making process by providing a streamlined set of data for investors.” said Dan DiCesare, founder of Uvest4U. The platform has earned the trust of many investors, and their positive reviews are a testament to it. Uvest4U tracks and analyzes trading signals from more than 80 sources. They are then summarized and put together into information that is easy to follow for everyone. It is interesting to note that only the big money managers usually have access to this kind of powerful information. But Uvest4U has changed that for individual investors to make smart decisions for their investments. Access to timely signal for trading is just one of the advantages of this AI-powered platform. It has been created by experts who understand that investing money is often difficult for people, especially with a wide range of information available. When is the right time to invest, where should one invest, and where should one not invest are just some of the crucial questions answered for investors by the platform. Uvest4U has thus leveled the playing field for non-professional investors by offering them the benefits of AI investing and granting them access to stock signals free of the cost and complexity usually monopolized by industry giants. The investing software has been created using AI and mathematical formulas available to money managers. With his tool, not only can individuals find brilliant investment opportunities, but they can also get the information they need to get through the investment lifecycle. From opening a position to adjusting stops and closing a position to make profits and avoid loss, the platform takes non-professional investors through it all. It’s very simple to register on the platform and get started in making smarter money decisions. The premium benefits include the ability to enter current investments and allow AI to alert one of the changes or strategy corrections. To learn more about the platform and to register, one can visit https://www.uvest4u.com/. About Uvest4U To empower the next generation of investors, the platform created by finance and technology experts helps users navigate the layered investing system. The AI-powered, do-it-yourself investing tool offers investors insights to make smart decisions. ### Media Contact Dan DiCesare Address: 6 Post Office Square, Boston, MA 02110 Phone: (781) 521-9281 URL: https://www.uvest4u.com/ Email: dan.dicesare@pgenllc.com Disclaimer The contents of this press release are for informational purposes only. You should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this press release constitutes a consultation or a solicitation for investment or the purchase or sale of any financial asset. Any investment decision should be made after consulting with a professional about your specific circumstances. The information provided in this press release does not constitute advice or investment opinion, and it should not be relied upon as such. It should not be considered a solicitation to buy or an offer to sell a security. It does not take into account any reader's particular investment objectives, financial situations, or needs. Readers should not consider it as financial advice and should consult with their financial advisor before making any investment decisions. Neither the distribution company nor its partners are responsible for any decision made on the basis of this press release. Any decision based on this press release should be made after consulting with a professional. The source of this press release, Uvest4U, must be contacted for any queries. Release ID: 851457

December 29, 2023 04:00 PM Eastern Standard Time

Image
Article thumbnail News Release

Awalé Resources sees fresh Newmont investment as statement of "confidence in the story"

Awalé Resources Ltd

Awalé Resources Ltd CEO Andrew Chubb speaks to Thomas Warner from Proactive after the junior exploration company closed a non-brokered private placement with Newmont Ventures Limited, a subsidiary of Newmont Corporation, raising nearly C$1 million. The funds will be allocated for greenfield exploration on the Odienné project permits and enhances Newmont's stake in the company to 15%. Originally holding 10% of Awalé through a joint venture, Newmont's investment dipped but was restored and increased at a premium price. This financial boost enables Awalé to accelerate exploration on their wholly-owned permits, which encircle the two properties jointly ventured with Newmont. Chubb suggests that the expanded investment from Newmont not only demonstrates trust in Awalé's operational approach but also signifies the potential of the district where they operate. Reflecting on 2023, Chubb expresses satisfaction with the company's progress. Contact Details Proactive +1 604-688-8158 na-editorial@proactiveinvestors.com

December 29, 2023 01:46 PM Eastern Standard Time

Video
Article thumbnail News Release

TNR Gold executive chair reports on an "important year" for the business

TNR Gold Corp

TNR Gold Corp Executive Chairman Kirill Klip speaks to Thomas Warner from Proactive about recent developments relevant to the green energy metals royalty and gold company. Klip starts by discussing progress at the Los Azules Copper, Gold, and Silver Project, saying that a total investment of $65 million from Rio Tinto in McEwen Copper, which is developing Los Azules, underscores the project's potential. Additionally, European automaking giant Stellantis joined as an investor this year, contributing to a combined investment of 72bln Argentinian pesos. Klip goes on to highlight the June 2023 release of a new preliminary economic assessment (PEA), revealing a 27% increase in total copper resource at Los Azules. Finally, Klip comments on the Mariana Lithium project. The timely sale of a portion of their Mariana Lithium royalty, coinciding with lithium's price peak, strategically eliminated the company's debts. With production expected to start in 2024, Klip expresses optimism about the project's future, marking a successful year for TNR Gold Corp and setting a positive outlook for 2024. Contact Details Proactive +1 604-688-8158 na-editorial@proactiveinvestors.com

December 29, 2023 01:41 PM Eastern Standard Time

Video
Article thumbnail News Release

Looking for a 100x? This Presale Memecoin Is Primed to Soar in 2024

RoundHouse Media

More than ever, investors from across the globe are turning to cryptocurrencies. Certainly, the stories of the meteoric rise of Bitcoin, $XRP, and Shiba Inu have influenced the growing number of investors seeking a 100x investment. While you might be late to get a 100x ROI from these top altcoins, there's still a great opportunity for you. A new crypto presale project, Galaxy Fox ($GFOX), has sparked excitement in the memecoin space over its innovative features. Let's find out why $GFOX has been projected to soar by 100x in 2024. >>BUY $GFOX TOKENS<< Galaxy Fox ($GFOX): Changing the Memecoin Narrative Many market experts have confirmed that 2024 will be a bull market for cryptocurrencies. While this has influenced the predictions of Galaxy Fox ($GFOX), it’s not the main reason why they are hyper-bullish about the new project. The main reason is that Galaxy Fox looks set to change the memecoin narrative. Traditionally, when meme coins are mentioned, they are linked with projects fuelled by only community hype and little to no utility. Galaxy Fox is looking to change this by introducing a ton of utility to its ecosystem. The Galaxy Fox ecosystem is built around a blockchain gaming ecosystem. Within the ecosystem is an exciting play-to-earn (P2E) game, some of the coolest NFTs integrated directly into the game, an NFT marketplace, and a merchandise store. The entire ecosystem is designed to encourage community participation. From the game to the merchandise store, users of Galaxy Fox are rewarded for their participation. The $GFOX ERC20 token will power the ecosystem. $GFOX is the meme coin to buy now because it has solved the tokenomics problem of most top names like Dogecoin. Instead of an infinite supply, just 5 billion $GFOX tokens will be available. To add decentralization, 70% will be sold during the project's crypto presale. To keep the project sustainable, 10% will be added to the liquidity pool. >>BUY $GFOX TOKENS<< In addition to this amazing tokenomics approach, $GFOX now has a token burn mechanism. Why Galaxy Fox ($GFOX) Can Achieve a 100x Return The 100x projections for Galaxy Fox are ambitious goals that only a few cryptos have ever achieved. So, how have market analysts projected that this new crypto presale project can yield a 100x ROI in the 2024 bull market? Firstly, the introduction of utility has brought massive demands to Galaxy Fox. The project hit the $1 million funding mark in just a few weeks after its crypto presale was announced. The project has now raised almost $1.4 million, highlighting the massive interest in the project. Since the project caters to two distinct communities, P2E gamers and meme coin lovers, its growth is expected to be rapid. Community expansion can generate momentum and contribute to the project's overall growth trajectory. Most crucially, a 100x increase in $GFOX is achievable because Galaxy Fox is at the forefront of a new macro trend: meme coins with utility. In the crypto market, history has shown that unusual ventures like these see the most development. Closing Thoughts As a new project looking to change the face of an entire sector, Galaxy Fox has been ranked as the top crypto to invest in for the 2024 bull market. Now's a great time to join the Galaxy Fox journey for only $0.00132. Stage 4 is nearly sold out, so best to get in early, before the next scheduled price increase. Visit the Galaxy Fox Presale today! Learn more about Galaxy Fox ($GFOX) here: Visit Galaxy Fox Presale | Join The Telegram Group | Follow Galaxy Fox on Twitter Memecoin market is saturated with silly dog coin knock-offs and dodgy Pepe joke coins. What was once a thriving and fun-filled space has lately devolved into a wasteland of coins that lack real utility or serious development or even something just to make you laugh, like OG memcoins of the past Doge and Shiba Inu once inspired. Contact Details Dean media@galaxyfox.io

December 29, 2023 01:00 PM Eastern Standard Time

Article thumbnail News Release

Whales and Justin Sun Accumulate Shiba Inu, Is There a Rally Coming ? Meme Moguls Price Hit New All-Time High

Meme Moguls

Shiba Inu (SHIB) recently gained a significant level of attention from whales, and one of them included Justin Sun, founder of TRON. As a result, many are now turning their attention to the cryptocurrency. But it's not the only project to gain an increase in its popularity, as Meme Moguls (MGLS) is also climbing, as it's nearly done with Stage 2 of its presale, following the rapid growth of its blockchain ICO. We will go over both to see which is the best new crypto to invest in. Meme Moguls (MGLS) to Become a Major Competitor With Innovative Ecosystem Meme Moguls (MGLS) will be an upcoming exchange in which users can access a Play-to-Earn (P2E) ecosystem where players can monetize the time they spend learning about the most effective trading strategies. The platform will feature a game intended to teach users how to invest and build wealth. Simulated trading will let them compete with friends in virtual stock market trading games while they also learn about investing strategies. As a result, they can learn new ways through which they can monetize their time and earn cash prizes and meme rewards. Every player will begin with a starting balance of $100,000 in virtual cash. This way, they can create a portfolio and complete challenges. There will also be NFT characters, which can be bought or sold. They can enhance the overall trading capabilities players have while also improving their trading conditions. The rarer the NFT, the better the conditions, such as leverage and spreads. Anyone will also be able to access Moguls World, a Metaverse where anyone can connect, mine tokens, join liquidity pools, and stake their tokens. To get more MGLS, players can contribute their existing tokens to the Meme Moguls staking pool. By doing so, they become eligible for rewards. The amount gained is based on their share of the pool and the percentage of the annual return. MGLS is seen as the best new crypto to invest in during its crypto ICO phase. Shiba Inu (SHIB) Gets Massive Attention From Whales Shiba Inu (SHIB) recently saw a major level of attention fueled by whale accumulation. According to data from Lookonchain, several notable investors turned their attention to Shiba Inu over the past month and purchased large amounts of the meme-inspired cryptocurrency. One of the whales includes Justin Sun, founder of TRON, as well as a number of anonymous wallet addresses. Fresh Wallet "0xa656" withdrew 237.87 billion Shiba Inu, totaling $2.56 million from Binance. Then, Justin Sun withdrew 577 billion SHIB worth $6.17 from Binance. Whale "0xfa22" and "0xF17f", presumed to be the same person, accumulated a total of 850 billion Shiba Inu from Binance. Whale "0x8652" started accumulating SHIB from Binance on August 9 and has so far accumulated 543.3 billion worth $5.8 million. Based on this, it's clear that whales are accumulating SHIB at a rapid rate. Summary Aside from Shiba Inu, another crypto is also getting attention. Meme Moguls is being accumulated rapidly as-well, as during Stage 3, the MGLS token is offered at just $0.0025. At the conclusion of the crypto ICO, analysts project an upswing of 100x. Visit Meme Moguls With the overnight sensations of memes like Pepe, Shiba Inu, and Dogecoin surging to a $1b market cap and making people overnight millionaires. Meme Moguls gives you the opportunity to trade these memes in a stock market-style meme trading platform. Meme Moguls and all cryptocurrencies are subject to significant price fluctuations and volatility. Investing in or holding Meme Moguls tokens carries substantial risks, including the potential for total loss. Past performance should not be considered indicative of future results. Contact Details Maverick contact@mememoguls.com Company Website https://mememoguls.com/

December 29, 2023 10:00 AM Central Standard Time

Image
Article thumbnail News Release

Dallas federal criminal defense attorney John Helms Explains When Can A Federal Criminal Defendant Appeal a Ruling Before The Case is Over?

Prodigy Press Wire

Recently, former President Donald Trump has appealed pretrial rulings denying him immunity from criminal prosecution and denying his claim of double jeopardy based on his impeachment proceeding. See United States v. Trump, No. 23-3228, in the United States Court of Appeals for the District of Columbia Circuit (2023). Because I am a federal criminal defense lawyer, some of my lawyer friends, clients, and families of clients have asked me why former President Trump can appeal these rulings and, in general, when federal criminal defendants can appeal a trial judge’s rulings before trial. I will answer those questions in this article. THE GENERAL RULE: YOU CAN ONLY APPEAL WHEN THE CASE IS OVER IN THE TRIAL COURT. As a matter of policy, we do not want parties in criminal (or civil, for that matter) cases to be able to take an immediate appeal of every ruling that a trial judge makes. Appeals take a long time—sometimes a year or more. So, if we allowed immediate appeals of every pretrial ruling, cases could bounce up and down between the trial court and the appeals court for years. In addition, many cases that could be resolved by a plea agreement for a guilty plea, which would avoid the need for appeals, could be bogged down with multiple appeals. Allowing immediate appeals of every pretrial ruling would make the system extremely inefficient and bogged down. For this reason, the general rule is that appeals can only be taken when the case is finished in the trial court—that is, when the trial court makes a “final decision.” In a criminal case, that generally means that the defendant is either acquitted or is convicted and sentenced. In order to promote this policy, Congress passed a statute that enacts it into law: 28 U.S.C. § 1291. It provides: “The courts of appeals (other than the United States Court of Appeals for the Federal Circuit) shall have jurisdiction of appeals from all final decisions of the district courts of the United States….” Id. (emphasis added). EXCEPTIONS TO THE GENERAL RULE. There are several exceptions to the general rule that you cannot appeal until the case is over in the trial court. In 1949, the United States Supreme Court held that certain rulings by trial courts are, effectively, “final” decisions, even though the case is not over in the trial court. See Cohen v. Beneficial Indus. Loan Corp., 337 U.S. 541 (1949). In Cohen, the Supreme Court described the type of order that is, effectively, “final”: The ruling must conclusively determine the disputed question; The disputed question is important and entirely separable from the merits of the case; and The ruling is effectively unappealable after a final judgment in the case. See id. at 546-47. This became known as the “collateral order doctrine.” In federal criminal cases, rulings that are recognized as falling within the collateral order doctrine include claims that a defendant is immune from criminal liability and claims that a prosecution is barred by double jeopardy. The denial of a claim of immunity “is an immediately appealable collateral order.” Wuterich v. Murtha, 562 F.3d 375, 381–82 (D.C. Cir. 2009) (immunity); see Abney v. United States, 431 U.S. 651, 659 (1977) (double jeopardy). Regarding immunity from criminal liability, this is considered appealable because a person entitled to immunity from prosecution is denied that immunity if the person is required to stand trial. The same logic applies to double jeopardy. That is, a person whose prosecution is barred by double jeopardy loses that protection if the person is required to stand trial a second time. An interesting type of pretrial appeal concerns a federal trial court’s denial of a motion to suppress evidence that law enforcement has allegedly obtained illegally. This might happen, for example, if the police search a person’s home without a search warrant and find illegal drugs. If the trial judge rules that the police needed a search warrant, the judge may make a ruling “suppressing” the drugs that the police found. This means that the drugs cannot be used as evidence in the defendant’s trial. If the Government cannot prove the defendant’s guilt without proving that the police found the drugs, the Government might have to dismiss the case. As far back as 1962, the Supreme Court held that a defendant cannot appeal a ruling denying a motion to suppress until after the case is over in the trial court. See Di Bella v. United States, 369 U.S. 121, 123-24 (1962). In other words, if the trial judge rules that law enforcement obtained the evidence legally and that it can be used in the defendant’s trial, the defendant can only appeal that ruling, if at all, after the defendant has been convicted and sentenced. On the other hand, Congress has specifically provided, by statute, that the Government can appeal a ruling granting a motion to suppress evidence if the evidence is important to the Government’s case. As set forth in 18 U.S.C. § 3731: An appeal by the United States shall lie to a court of appeals from a decision or order of a district court suppressing or excluding evidence or requiring the return of seized property in a criminal proceeding, not made after the defendant has been put in jeopardy and before the verdict or finding on an indictment or information, if the United States attorney certifies to the district court that the appeal is not taken for purpose of delay and that the evidence is a substantial proof of a fact material in the proceeding. The reason for this statute is that, without the possibility of an immediate appeal, the Government might have to dismiss the case, which would end the case and prevent an appeal. Therefore, Congress provided a means for the Government to appeal rulings suppressing evidence without having to dismiss the case. I recently had this happen. I won a motion to suppress statements made by the defendant who had not had been given his Miranda rights, and the Government immediately appealed because they did not think they could win the case without those statements. See United States v. Coulter, No. 3:19-CR-00068, in the United States District Court for the Northern District of Texas (October 2, 2020) (United States’ Notice of Appeal). It is important to note that a defendant who loses a motion to suppress evidence can, with the agreement of the judge and the Government, plead guilty to the offense and reserve the right to appeal the ruling on the motion to suppress. See Fed. R. Crim. P. 11(a)(2). If the defendant wins the appeal on the motion to suppress, the defendant can then withdraw the guilty plea and proceed to trial. See id. Another exception to the general rule that you cannot appeal rulings before the end of the case in the trial court concerns pretrial detention orders. A detention order is a ruling that a defendant will be held in custody while the case proceeds toward trial. A United States Magistrate Judge will normally rule on this issue at a “detention hearing” early in the case. By statute, if a Magistrate Judge orders a defendant to be held in custody, the defendant can appeal the ruling to a United States District Judge. See 18 U.S.C. § 3145(b). The Government can do the same if the Magistrate Judge rules that the defendant should not be held in custody. See 18 U.S.C. § 3145(a). Either the defendant or the Government can then appeal a ruling from a United States District Judge to the United States Court of Appeals. See 18 U.S.C. § 3145(c). The reason for these provisions is that a person’s detention, or lack of detention, cannot be effectively reviewed after the case is over. If the person should not be detained, and they are, an appeal after the case is over cannot undo the detention during the case. Likewise, f the person should be detained, and they are not, an appeal after the case is over cannot cause the person to be detained. WHY WAS FORMER PRESIDENT TRUMP ALLOWED TO APPEAL WHEN HE DID? Former President Trump was allowed to appeal two issues before the end of his criminal case in the trial court: (1) Whether Presidents are immune from criminal prosecution for what they do during their presidency; and (2) Whether President Trump’s impeachment trial means that he cannot be criminally prosecuted under the Double Jeopardy clause of the Fifth Amendment of the United States Constitution. Both of these issues fit within the collateral order doctrine discussed above, so he can appeal them before the case is over in the trial court. The fact that he can appeal these issues has nothing to do with whether he might win them on appeal. Frankly, I think both of former President Trump’s arguments border on being completely frivolous. I do not think any serious lawyer believes he can or should win either of them. They are pure delay tactics that he hopes will drag out the case until after the election, which he hopes he will win, so that he can either try to pardon himself (again, frivolous in my view), or stop the prosecution by the Justice Department. AS A FEDERAL CRIMINAL DEFENDANT, WHAT ISSUES CAN YOU APPEAL RIGHT AWAY? If you or a loved one is charged in a federal criminal case, your ability to appeal pretrial rulings before the case is over in the trial court is very limited. You can immediately appeal if the trial court denies a claim of immunity from prosecution, denies a motion to dismiss based on double jeopardy, or orders you or your loved one detained while the case proceeds. There may be other situations in which you can immediately appeal, but these are the most likely ones. If you or a loved one cannot immediately appeal a ruling, it may be possible to appeal the ruling after conviction and sentence. This will depend on a number of factors, including whether the was convicted in a trial or whether the defendant pleaded guilty and reserved the right to appeal. Federal criminal cases are complicated and specialized. An effective defense to federal criminal charges requires the experience and skill of a lawyer who knows federal criminal law and procedure. If you or a loved one is charged with a federal crime, you should immediately contact a federal criminal defense lawyer with the experience, skill, knowledge, and track record who can get the best possible result in the case. Media contact: William Perras 214-666-8010 Neither KISS PR nor its distribution partners are liable for the news provided and are not directly or indirectly responsible for any loss or damage. All decisions made by recipients are at their own risk. Please contact the issuing source for any inquiries or information. Release ID: 834487

December 29, 2023 10:00 AM Eastern Standard Time

Article thumbnail News Release

NKGen Biotech Advances Alzheimer's Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

NKGen Biotech, Inc.

SANTA ANA, Calif., Dec. 29, 2023 - (Plato / Amplifi via 500NewsWire) -- NKGen Biotech, Inc. ( Nasdaq: NKGN ) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced cytotoxicity and activating receptor expression. Dosing Details: The initial patient in the Phase 1/2a trial received a substantial dose of 6 billion cells, 50% more than the maximum dosing from the Phase 1 trial. This trial aims to evaluate the safety and tolerability of SNK01 in participants with moderate AD. Trial Structure: The Phase 1 is an open-label safety assessment determining the maximum tolerated dose and/or recommended Phase 2 dose of SNK01. The subsequent Phase 2 is a randomized double-blind trial assessing both safety and efficacy in moderate AD patients. Addressing Advanced AD Population: NKGen's focus on the moderate AD population, lacking approved disease-modifying therapies, distinguishes its approach from traditional treatments that target milder conditions. Previous findings indicate the safety of enhanced NK cells, administered intravenously, in positively impacting brain protein aggregates and neuroinflammation. Optimizing Dosing Regimen: Despite suboptimal dosing in 2/3 of Phase 1 trial patients, 90% exhibited stable or improved cognitive function. The new randomized trial plans to administer 6 billion cells per dose every three weeks for a year, totaling 17 doses. This intensified dosing regimen aims to demonstrate enhanced cognitive benefits and greater effects on protein and neuroinflammation levels. NKGen Biotech's commitment to advancing NK cell therapeutics positions SNK01 as a potential breakthrough in the treatment of moderate Alzheimer's disease, addressing a critical gap in available therapies. The Phase 1/2a trial marks a significant step forward in evaluating the safety and efficacy of this promising autologous NK cell product. Source: Plato / Amplifi Contact Details Plato / Amplifi dz@amplifiPR.com

December 29, 2023 07:30 AM Eastern Standard Time

Image
Article thumbnail News Release

Ultrahuman introduces ground-breaking pregnancy insights on the Ring AIR

Ultrahuman

Ultrahuman, a pioneer in cutting-edge wearable technology, introduces a groundbreaking capability with 'Pregnancy Insights' on the Ultrahuman Ring AIR, setting a global milestone as the first smart ring to deliver personalized biomarkers aligned with trimesters. This innovative capability empowers expecting mothers to seamlessly correlate their biomarkers with trimester progression through individually tailored scores. Pregnancy is a remarkable biological phenomenon that exemplifies the intricate dance of cellular and hormonal orchestration, initiating new life. Hormonal interplay, particularly involving human chorionic gonadotropin (hCG), progesterone, and estrogen, regulates the delicate balance necessary for a successful pregnancy. This interplay causes biomarkers to vary due to physiological demands. With Ultrahuman Ring AIR, expecting mothers can look deeper into their Sleeping patterns, Movement, Heart Rate (HR), Heart Rate Variability (HRV), Temperature, and Resting Heart Rate (RHR), tailored to the specific trimester of their pregnancy journey. For instance, in the first trimester, heightened RHR signifies the body's dedicated efforts in early pregnancy development. The Ring AIR, equipped with advanced algorithms, offers in-depth yet easily comprehensible pregnancy insights. These insights don't only give a snapshot into the inner workings of the body but are also accompanied with timely nudges to manage hydration, encourage gentle exercise, and a balanced diet. Common variations in HRV and a slight rise in body temperature during the first trimester are intelligently interpreted by the Ring AIR as natural responses to the demands of pregnancy, without penalising the scores. This adaptive approach ensures a supportive and informed experience for expecting mothers throughout their pregnancy journey. Mohit Kumar, Founder and CEO, Ultrahuman, spoke on the groundbreaking capability stating, "We’re doubling down on our commitment to women’s health by making actionable health data available to pregnant women. There’s so much more to come in 2024 and this is just the beginning." This introduction of ‘Pregnancy Insights’ on the Ring AIR underscores the company’s dedication to enhancing the well-being and deeper understanding of women’s health during the transformative journey of pregnancy. About Ultrahuman Ultrahuman is the world's most advanced metabolic fitness platform. Ultrahuman’s products include the Ultrahuman M1(continuous glucose monitoring sensor), the Ultrahuman Ring and Blood Vision, a preventive blood testing platform with the pioneering UltraTrace™ technology. By collating different biomarkers, Ultrahuman is helping people improve their energy levels and lifestyle, track their workout, sleep and recovery, and avoid metabolic disorders. For more information and updates on Ultrahuman, please visit ultrahuman.com or follow us on Facebook, Instagram, Twitter, LinkedIn, and YouTube. Contact Details Ultrahuman Bilal Mahmood b.mahmood@stockwoodstrategy.com Company Website https://www.ultrahuman.com/

December 29, 2023 04:30 AM Eastern Standard Time

Image
1 ... 515516517518519 ... 3764